Skip to content

The Effect of a Training Programme in the Variation of Fitness Parameters, Physiological, Hematological and Biochemical Indicators of Soccer Players During the Preseason Period

The Effect of a Training Programme in the Variation of Fitness Parameters, Physiological, Hematological and Biochemical Indicators of Soccer Players During the Preseason Period

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07170930
Enrollment
24
Registered
2025-09-12
Start date
2025-07-01
Completion date
2025-09-15
Last updated
2025-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athletic Performance, Exercise-induced Inflammation, Exercise Physiology, Exercise Test, Inflammation, Muscle Damage, Physical Fitness, Pre-season Training, Soccer

Keywords

Pre-season training, Match-play exposure, Physiological adaptation, Biochemical markers, Recovery strategies, Training intensity, Physiological stress, Football, Aerobic-anaerobic, Effect, Athletic, Performance adaptation

Brief summary

The goal of this study is to investigate the effects of varying friendly match-play exposure during the late pre-season on physiological, biochemical, and performance adaptations in soccer players. It is hypothesized that (i) significant changes will occur across the pre-season in both the extended- and limited-play groups when analysed independently; (ii) distinct group-specific adaptations will emerge by the end of the preparatory period; and (iii) match-play exposure, when analysed across all participants, will be significantly correlated with physiological and performance outcomes at pre-season completion. Players from a randomly selected team will be assessed at three time points: pre-season start, mid-pre-season (MPS), and pre-competition phase (PC). Assessments will include anthropometry, physical performance, and markers of muscle damage, inflammation, hormonal status, and haematology. Based on the total match-play time of 8 friendly games during the late pre-season, players will be retrospectively categorised into extended-play (EP) and limited-play (LP) cohorts.time of 8 friendly games during the late pre-season, players will be retrospectively categorised into extended-play (EP) and limited-play (LP) cohorts.

Interventions

OTHERFriendly Match-Play Exposure: extended vs. limited

This research explores the multidimensional physiological and biochemical responses to differing volumes of friendly match-play (i.e., extended vs. limited) during the late pre-season phase in soccer players.

Sponsors

Emmanouil D. Zacharakis
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Male participants * Aged 18 years or older * Non-smokers * Injury-free for the past 6 months * Medication-free for the past 6 months * Abstinent from alcohol * Living at an altitude below 1500 meters * Committed exclusively to soccer (no participation in other sports)

Exclusion criteria

* History of serious injuries (e.g., fractures, ligament tears) within the past 6 months * Chronic medical conditions such as cardiovascular disease, diabetes, or respiratory disorders * Current use of performance-enhancing drugs or supplements * Participation in non-soccer-related sports or activities during the study period

Design outcomes

Primary

MeasureTime frameDescription
Body MassEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Body mass measured at standard anatomical sites using a calibrated scale to track longitudinal changes over the pre-season. Unit of Measure: kg
Body FatEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Body fat percentage measured using skinfold calipers at standard sites to monitor longitudinal changes. Unit of Measure: %
Rate of Perceived Exertion (RPE)Each measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Participants rate exertion during standardized training sessions using the Borg Scale (6 = no exertion, 20 = maximal exertion). Unit of Measure: Borg 6-20 scale
GlucoseEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Fasting blood glucose measured to track metabolic changes over pre-season. Unit of Measure: mg/dL
CholesterolEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Total serum cholesterol measured to assess lipid profile adaptations. Unit of Measure: mg/dL
TriglyceridesEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Serum triglycerides measured to monitor metabolic response to training. Unit of Measure: mg/dL
SGOT (AST)Each measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Serum glutamic-oxaloacetic transaminase measured to assess liver/muscle stress. Unit of Measure: U/L
SGPT (ALT)Each measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Serum glutamic-pyruvic transaminase measured to monitor liver/muscle stress. Unit of Measure: U/L
Creatine Phosphokinase (CPK)Each measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: CPK measured to detect skeletal muscle damage. Unit of Measure: U/L
MyoglobinEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Myoglobin measured as a marker of muscle damage. Unit of Measure: ng/mL
IronEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Serum iron measured to assess iron status. Unit of Measure: µg/dL
FerritinEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Serum ferritin measured to monitor iron storage. Unit of Measure: ng/mL
C-Reactive Protein (CRP)Each measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: CRP measured as a marker of systemic inflammation. Unit of Measure: mg/L
High-sensitivity CRP (hs-CRP)Each measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: hs-CRP measured to detect low-grade inflammation. Unit of Measure: mg/L
Interleukin-6 (IL-6)Each measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: IL-6 measured from serum to assess inflammatory response. Unit of Measure: pg/mL
Tumor Necrosis Factor-alpha (TNF-α)Each measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: TNF-α measured as a marker of systemic inflammation. Unit of Measure: pg/mL
TestosteroneEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Serum testosterone measured to assess hormonal adaptations. Unit of Measure: ng/dL
CortisolEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Serum cortisol measured to monitor stress response. Unit of Measure: µg/dL
Testosterone-Cortisol RatioEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Calculated ratio to estimate anabolic-catabolic balance. Unit of Measure: Ratio
Red Blood Cells (RBC)Each measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: RBC count measured from blood to assess oxygen transport capacity. Unit of Measure: million cells/µL
HemoglobinEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Hemoglobin measured to evaluate oxygen-carrying capacity. Unit of Measure: g/dL
HematocritEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Hematocrit measured as percentage of RBC in blood. Unit of Measure: %
White Blood Cells (WBC)Each measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: WBC count measured to monitor immune function. Unit of Measure: cells/µL
PlateletsEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Platelet count measured to assess hematological health. Unit of Measure: cells/µL
Countermovement Jump HeightEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Jump height measured (cm) to assess lower-limb explosive power. Unit of Measure: cm
Knee Extensor Power, Dominant LegEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Measured using isokinetic dynamometer. Unit of Measure: Watts
Knee Extensor Power, Non-Dominant LegEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Measured using isokinetic dynamometer. Unit of Measure: Watts
Knee Flexor Power, Dominant LegEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Measured using isokinetic dynamometer. Unit of Measure: Watts
Knee Flexor Power, Non-Dominant LegEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Measured using isokinetic dynamometer. Unit of Measure: Watts
10-m Sprint TimeEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Sprint time measured using photocell gates; lower times indicate better performance. Unit of Measure: seconds
T-Test AgilityEach measure assessed at Baseline (pre-season start), 4 weeks (mid-pre-season), and 8 weeks (pre-competition phase).Description: Participants perform T-test agility course; lower times indicate better agility. Unit of Measure: seconds

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026